SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker

Nucleic Acids Res. 2022 Jan 7;50(D1):D1368-D1372. doi: 10.1093/nar/gkab1050.

ABSTRACT

In 2013, we released the Structural Antibody Database (SAbDab), a publicly available repository of experimentally determined antibody structures. In the interim, the rapid increase in the number of antibody structure depositions to the Protein Data Bank, driven primarily by increased interest in antibodies as biotherapeutics, has led us to implement several improvements to the original database infrastructure. These include the development of SAbDab-nano, a sub-database that tracks nanobodies (heavy chain-only antibodies) which have seen a particular growth in attention from both the academic and pharmaceutical research communities over the past few years. Both SAbDab and SAbDab-nano are updated weekly, comprehensively annotated with the latest features described here, and are freely accessible at opig.stats.ox.ac.uk/webapps/newsabdab/.

PMID:34986602 | PMC:PMC8728266 | DOI:10.1093/nar/gkab1050